Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
What's New
Your Valuation
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
NewAmsterdam Pharma
Create a narrative
NewAmsterdam Pharma Community
NasdaqGM:NAMS Community
0
Narratives
written by author
1
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Community Investing Ideas
NewAmsterdam Pharma
Popular
Undervalued
Overvalued
There are no community narratives available.
Recently
Updated Narratives
WA
Wane_Investment_House
on Champion Breweries
·
Updated
about 17 hours ago
CHAMPION BREWERIES PLC Q3 Result – Earnings Rebound Driven by Strong Volume Growth Amid Rising Finance Costs and Working Capital Expansion
Fair Value:
₦15
8.7% undervalued
intrinsic discount
13
followers
users have followed this narrative
·
6
comments
users have commented on this narrative
·
0
likes
users have liked this narrative
WA
Wane_Investment_House
on Caverton Offshore Support Group
·
Updated
about 17 hours ago
Caverton Offshore Support Group Plc Q3 Result – Challenging Period Amid FX Volatility and High Finance Costs
Fair Value:
₦6
5.8% undervalued
intrinsic discount
13
followers
users have followed this narrative
·
7
comments
users have commented on this narrative
·
0
likes
users have liked this narrative
WO
woodworthfund
on Willamette Valley Vineyards
·
Updated
about 23 hours ago
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Fair Value:
US$2
26.0% overvalued
intrinsic discount
1
follower
users have followed this narrative
·
0
comments
users have commented on this narrative
·
0
likes
users have liked this narrative
Popular Narratives
OS
oscargarcia
on Alphabet
·
Updated
5 days ago
The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.
Fair Value:
US$340
16.4% undervalued
intrinsic discount
119
followers
users have followed this narrative
·
5
comments
users have commented on this narrative
·
15
likes
users have liked this narrative
AN
AnalystConsensusTarget
on NVIDIA
·
Updated
5 days ago
NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
Fair Value:
US$232.79
22.1% undervalued
intrinsic discount
908
followers
users have followed this narrative
·
5
comments
users have commented on this narrative
·
21
likes
users have liked this narrative
AM
AmirV
on Paradigm Biopharmaceuticals
·
Updated
about 2 months ago
Paradigm Biopharmaceuticals Will Lead Osteoarthritis Treatment with Zilosul's FDA Success
Fair Value:
AU$5.5
94.2% undervalued
intrinsic discount
68
followers
users have followed this narrative
·
3
comments
users have commented on this narrative
·
18
likes
users have liked this narrative
Your Valuation for
NAMS
NAMS
NewAmsterdam Pharma
Your Fair Value
US$
Current Price
US$38.91
207.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-352m
384m
2015
2018
2021
2024
2025
2027
2030
Revenue US$384.3m
Earnings US$80.6m
Advanced
Set Fair Value